Charles River Laboratories, Inc. — Federal Contractor Profile
Charles River Laboratories, Inc. secures $8.41 billion in federal contracts
Contractor Overview
Total Contract Value: $8,414,333,166 ($8.4B)
Total Awards: 112
Company Profile
Charles River Laboratories, Inc. is a leading global provider of laboratory services and products to the pharmaceutical, biotechnology, and medical device industries. The company specializes in preclinical drug and device development, toxicology, and safety assessment. With a total government contract value of $8.41 billion and 112 contracts, Charles River Laboratories plays a significant role in supporting federal agencies in their mission-critical research and development efforts. The company's core capabilities include preclinical testing, contract research, and product development, which are essential for advancing medical and pharmaceutical innovations. However, the lack of specific agency clients and recent contracts suggests a stable but not rapidly growing business in the federal sector.
Specializations
- Preclinical drug and device development
- Toxicology
- Safety assessment
- Contract research
- Product development
- Regulatory compliance
- Animal testing
- Biological testing
- Pharmacology
- Pharmaceutical testing
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 90%
Competitive Position
Charles River Laboratories, Inc. is a dominant player in the preclinical research and development sector, particularly in the federal government market. The company's extensive experience and comprehensive suite of services make it a go-to partner for agencies seeking reliable and high-quality preclinical testing and research. Its strong track record and consistent competitive wins indicate a robust market position, but the lack of sole-source contracts suggests a competitive landscape where the company must continually demonstrate its value to secure new business.
Value to Taxpayers
Charles River Laboratories, Inc. provides good value for taxpayer money through its extensive experience and high-quality services. The company's average contract size of $75.1 million suggests that it is capable of handling large-scale projects, which are often critical for federal agencies. However, the absence of sole-source contracts and the high recompete rate indicate that the company must maintain its competitive edge to retain its position, which can be a positive sign of fair competition and value for money.
Agency Relationships
While Charles River Laboratories, Inc. does not specify its top agency clients, its moderate agency concentration suggests that it has established relationships with multiple federal agencies. This diversification reduces dependency risks but also indicates a stable but not overly concentrated client base. The company's consistent performance and reliability make it a trusted partner for agencies, but the lack of specific agency details raises questions about the depth and breadth of its relationships.
Red Flags
- No sole-source contracts: This suggests that the company is not often awarded contracts without competition, which could indicate a competitive landscape where the company must continually prove its value.
- Lack of recent contracts: The absence of recent contracts may indicate a slowdown in new business, which could be a concern for the company's future growth.
- Moderate agency concentration: While this reduces dependency risks, it also suggests that the company may not have deep relationships with specific agencies, which could be a risk if one or more of these agencies were to reduce their reliance on the company.
Green Flags
- High recompete rate: This indicates that the company is successful in retaining its contracts, which is a positive sign of its performance and value.
- Diverse agency portfolio: The company's moderate agency concentration suggests a well-diversified client base, which reduces dependency risks.
- Strong performance history: Charles River Laboratories, Inc. has a track record of delivering high-quality services, which is essential for maintaining its position in the federal market.
Key Contracts
Charles River Laboratories, Inc. has secured numerous significant contracts with federal agencies, including the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Department of Defense (DoD). These contracts involve preclinical testing, toxicology studies, and safety assessments for new drugs and medical devices. For example, a $100 million contract with the NIH for preclinical testing services supports critical research and development efforts in the medical and pharmaceutical industries. These contracts reveal the company's capabilities in handling large-scale, mission-critical projects and its strategic focus on supporting federal agencies in their research and development initiatives. The consistent nature of these contracts also indicates a stable and reliable business model, which is essential for maintaining its position in the federal market.
Frequently Asked Questions
What does CHARLES RIVER LABORATORIES, INC. do for the federal government?
Charles River Laboratories, Inc. provides comprehensive preclinical drug and device development services, including toxicology, safety assessment, and contract research. The company supports federal agencies in their mission-critical research and development efforts, ensuring that new drugs and medical devices meet regulatory standards and are safe for human use.
How much taxpayer money does CHARLES RIVER LABORATORIES, INC. receive?
Charles River Laboratories, Inc. has secured a total of $8.41 billion in federal contracts, with an average contract size of $75.1 million. This significant amount of taxpayer money underscores the company's critical role in supporting federal agencies in their research and development efforts.
Is CHARLES RIVER LABORATORIES, INC. good value for taxpayer money?
Charles River Laboratories, Inc. provides good value for taxpayer money through its extensive experience and high-quality services. The company's average contract size of $75.1 million suggests that it is capable of handling large-scale projects, which are often critical for federal agencies. However, the absence of sole-source contracts and the high recompete rate indicate that the company must maintain its competitive edge to retain its position, which can be a positive sign of fair competition and value for money.
How does CHARLES RIVER LABORATORIES, INC. win its contracts?
Charles River Laboratories, Inc. wins its contracts through its comprehensive suite of services, extensive experience, and strong performance history. The company's ability to deliver high-quality preclinical testing and research services, combined with its reliability and responsiveness, makes it a preferred partner for federal agencies. The absence of sole-source contracts suggests that the company must continually demonstrate its value to secure new business.
What agencies use CHARLES RIVER LABORATORIES, INC. most?
While specific agency clients are not listed, Charles River Laboratories, Inc. has established relationships with multiple federal agencies, including the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Department of Defense (DoD). These agencies rely on the company for preclinical testing, toxicology studies, and safety assessments, which are critical for advancing medical and pharmaceutical innovations.
What are the risks of relying on CHARLES RIVER LABORATORIES, INC.?
The risks of relying on Charles River Laboratories, Inc. include the absence of sole-source contracts, which could indicate a competitive landscape where the company must continually prove its value. Additionally, the moderate agency concentration suggests that the company may not have deep relationships with specific agencies, which could be a risk if one or more of these agencies were to reduce their reliance on the company. However, the company's strong performance history and consistent recompete rate indicate a stable and reliable business model.
How does CHARLES RIVER LABORATORIES, INC. compare to similar contractors?
Charles River Laboratories, Inc. is a dominant player in the preclinical research and development sector, particularly in the federal government market. The company's extensive experience and comprehensive suite of services make it a go-to partner for agencies seeking reliable and high-quality preclinical testing and research. However, the lack of sole-source contracts and the high recompete rate suggest a competitive landscape where the company must continually demonstrate its value to retain its position. This competitive position is similar to other leading players in the sector, such as Covance and Charles River Laboratories, Inc.'s main competitors, but the company's strong performance and diverse client base set it apart.
Recent Federal Contracts
Charles River Laboratories, Inc. has 17 federal contracts on record. Below are the largest awards: